Differential expression of gut miRNAs in idiopathic Parkinson's disease

Anna Kurz1, Rohit Kumar2, Bernd H Northoff3

  • 1Department of Neurology, Ludwig Maximilian University, Munich, Germany; Department of Translational Neurodegeneration, German Centre for Neurodegenerative Diseases (DZNE), Munich, Germany.

Abstract

Insights

MicroRNA hsa-miR-486-5p is enriched in colonic biopsies of Parkinson's disease (PD) patients, suggesting its potential as a diagnostic biomarker and offering insights into PD pathogenesis.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Gastroenterology

Background:

  • Idiopathic Parkinson's disease (PD) is a neurodegenerative disorder with gastrointestinal manifestations.
  • MicroRNAs (miRNAs) are implicated in various cellular processes and diseases.

Purpose of the Study:

  • To investigate miRNA expression in colonic biopsies from PD patients.
  • To assess the diagnostic value of miRNAs as biomarkers for PD.
  • To explore the mechanistic role of miRNAs in PD onset and progression.

Main Methods:

  • Prospective recruitment of PD patients (n=13) and healthy controls (n=17).
  • Collection of routine colonic biopsies for RNA extraction.
  • Quantification of miRNA expression using Illumina High-Throughput Sequencing.

Main Results:

  • Significant submucosal enrichment of hsa-miR-486-5p in PD patient biopsies compared to controls.
  • Correlation of miR-486-5p expression with age and PD severity (UPDRS, Hoehn & Yahr scale).
  • Identification of 301 gene targets affected by miR-486-5p, involved in enteric nervous system processes.

Conclusions:

  • Submucosal miR-486-5p enrichment in colonic biopsies is a potential PD biomarker.
  • miR-486-5p gene targets provide insights into PD pathogenesis and GI dysfunction in PD.
  • Further investigation of miR-486-5p can elucidate molecular mechanisms underlying PD.

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.8K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
606
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K